Sharpless On His Future And Zolgensma's Problems, Mylan's Insulin Complete Response

Citeline Podcasts

English - September 06, 2019 16:19 - 26 minutes - 24.2 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Ed Cox Departs FDA, J&J Loses Opioid Lawsuit And Industry Comments On Clinical Study Reports

Next Episode: Device Week, 6 September, 2019 – Connected Health Summit's Digital Health Focus;

Pink Sheet reporters discuss Acting FDA Commissioner Norman Sharpless' future, his comments on the Zolgensma data manipulation scandal, and a setback in Mylan's efforts to move a follow-on insulin application.